Epi Vax Therapeutics, Inc. reported raising $370,000 in an initial SEC Form D filing, from an offering of $370,000
Amount Raised
$370,000
Round Type
Seed
ProvidenceBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as EpiVax Oncology, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Vizgen raised $37M on April 8, 2021.
- selectIon raised $5.1M on April 8, 2021.
- Ventus Therapeutics raised $100M (Series B) on April 8, 2021.
- Revel Pharmaceuticals Inc. raised $800K (Seed) on April 8, 2021.
- Vizgen raised $37M (Series B) on April 7, 2021.
- Courtagen Life Sciences, Inc. raised $2.7M (Seed) on April 7, 2021.
Who to call at EpiVax Oncology, Inc., and when
A new round usually means EpiVax Oncology, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EpiVax Oncology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EpiVax Oncology, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EpiVax Oncology, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EpiVax Oncology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
EpiVax Oncology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.